151 related articles for article (PubMed ID: 16650763)
1. Privileged structure based ligands for melanocortin-4 receptors--aliphatic piperazine derivatives.
Briner K; Collado I; Fisher MJ; García-Paredes C; Husain S; Kuklish SL; Mateo AI; O'Brien TP; Ornstein PL; Zgombick J; de Frutos O
Bioorg Med Chem Lett; 2006 Jul; 16(13):3449-53. PubMed ID: 16650763
[TBL] [Abstract][Full Text] [Related]
2. Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivatives.
Fisher MJ; Backer RT; Collado I; de Frutos O; Husain S; Hsiung HM; Kuklish SL; Mateo AI; Mullaney JT; Ornstein PL; Paredes CG; O'Brian TP; Richardson TI; Shah J; Zgombick JM; Briner K
Bioorg Med Chem Lett; 2005 Nov; 15(22):4973-8. PubMed ID: 16169215
[TBL] [Abstract][Full Text] [Related]
3. Privileged structure based ligands for melanocortin receptors--4,4-disubstituted piperidine derivatives.
Kuklish SL; Backer RT; Briner K; Doecke CW; Husain S; Mullaney JT; Ornstein PL; Zgombick JM; O'Brien TP; Fisher MJ
Bioorg Med Chem Lett; 2006 Jul; 16(14):3843-6. PubMed ID: 16697186
[TBL] [Abstract][Full Text] [Related]
4. Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands.
Hong Q; Bakshi RK; Dellureficio J; He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Tang R; Kalyani RN; Macneil T; Vongs A; Rosenblum CI; Weinberg DH; Peng Q; Tamvakopoulos C; Miller RR; Stearns RA; Cashen D; Martin WJ; Chen AS; Metzger JM; Chen HY; Strack AM; Fong TM; Maclntyre E; Van der Ploeg LH; Wyvratt MJ; Nargund RP
Bioorg Med Chem Lett; 2010 Aug; 20(15):4483-6. PubMed ID: 20598533
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of trans-4-(4-chlorophenyl)pyrrolidine-3-carboxamides of piperazinecyclohexanes as ligands for the melanocortin-4 receptor.
Chen CW; Tran JA; Fleck BA; Tucci FC; Jiang W; Chen C
Bioorg Med Chem Lett; 2007 Dec; 17(24):6825-31. PubMed ID: 17964151
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor.
Shi Q; Ornstein PL; Briner K; Richardson TI; Arnold MB; Backer RT; Buckmaster JL; Canada EJ; Doecke CW; Hertel LW; Honigschmidt N; Hsiung HM; Husain S; Kuklish SL; Martinelli MJ; Mullaney JT; O'Brien TP; Reinhard MR; Rothhaar R; Shah J; Wu Z; Xie C; Zgombick JM; Fisher MJ
Bioorg Med Chem Lett; 2006 May; 16(9):2341-6. PubMed ID: 16297618
[TBL] [Abstract][Full Text] [Related]
7. Propionylpiperazines as human melanocortin-4 receptor ligands.
Chen CW; Tran JA; Jiang W; Tucci FC; Arellano M; Wen J; Fleck BA; Marinkovic D; White NS; Pontillo J; Saunders J; Madan A; Foster AC; Chen C
Bioorg Med Chem Lett; 2006 Sep; 16(18):4800-3. PubMed ID: 16824757
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands.
Marinkovic D; Tucci FC; Tran JA; Fleck BA; Wen J; Chen C
Bioorg Med Chem Lett; 2008 Sep; 18(17):4817-22. PubMed ID: 18682322
[TBL] [Abstract][Full Text] [Related]
9. Syntheses of tetrahydrothiophenes and tetrahydrofurans and studies of their derivatives as melanocortin-4 receptor ligands.
Tran JA; Chen CW; Tucci FC; Jiang W; Fleck BA; Chen C
Bioorg Med Chem Lett; 2008 Feb; 18(3):1124-30. PubMed ID: 18082401
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists.
Tian X; Mishra RK; Switzer AG; Hu XE; Kim N; Mazur AW; Ebetino FH; Wos JA; Crossdoersen D; Pinney BB; Farmer JA; Sheldon RJ
Bioorg Med Chem Lett; 2006 Sep; 16(17):4668-73. PubMed ID: 16766182
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.
Richardson TI; Ornstein PL; Briner K; Fisher MJ; Backer RT; Biggers CK; Clay MP; Emmerson PJ; Hertel LW; Hsiung HM; Husain S; Kahl SD; Lee JA; Lindstrom TD; Martinelli MJ; Mayer JP; Mullaney JT; O'Brien TP; Pawlak JM; Revell KD; Shah J; Zgombick JM; Herr RJ; Melekhov A; Sampson PB; King CH
J Med Chem; 2004 Jan; 47(3):744-55. PubMed ID: 14736255
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.
Chen C; Tucci FC; Jiang W; Tran JA; Fleck BA; Hoare SR; Wen J; Chen T; Johns M; Markison S; Foster AC; Marinkovic D; Chen CW; Arellano M; Harman J; Saunders J; Bozigian H; Marks D
Bioorg Med Chem; 2008 May; 16(10):5606-18. PubMed ID: 18417348
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
[TBL] [Abstract][Full Text] [Related]
14. Novel piperazines: potent melanocortin-4 receptor antagonists with anxiolytic-like activity.
Nozawa D; Okubo T; Ishii T; Takamori K; Chaki S; Okuyama S; Nakazato A
Bioorg Med Chem; 2007 Mar; 15(6):2375-85. PubMed ID: 17267226
[TBL] [Abstract][Full Text] [Related]
15. Arylpropionylpiperazines as antagonists of the human melanocortin-4 receptor.
Jiang W; Tucci FC; Chen CW; Arellano M; Tran JA; White NS; Marinkovic D; Pontillo J; Fleck BA; Wen J; Saunders J; Madan A; Foster AC; Chen C
Bioorg Med Chem Lett; 2006 Sep; 16(17):4674-8. PubMed ID: 16777413
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies on a series of cyclohexylpiperazines bearing a phanylacetamide as ligands of the human melanocortin-4 receptor.
Pontillo J; Tran JA; White NS; Arellano M; Fleck BA; Marinkovic D; Tucci FC; Saunders J; Foster AC; Chen C
Bioorg Med Chem Lett; 2005 Dec; 15(23):5237-40. PubMed ID: 16183282
[TBL] [Abstract][Full Text] [Related]
17. 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists.
Palucki BL; Park MK; Nargund RP; Tang R; MacNeil T; Weinberg DH; Vongs A; Rosenblum CI; Doss GA; Miller RR; Stearns RA; Peng Q; Tamvakopoulos C; Van der Ploeg LH; Patchett AA
Bioorg Med Chem Lett; 2005 Apr; 15(8):1993-6. PubMed ID: 15808454
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor.
Nozawa D; Okubo T; Ishii T; Kakinuma H; Chaki S; Okuyama S; Nakazato A
Bioorg Med Chem; 2007 Mar; 15(5):1989-2005. PubMed ID: 17234422
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.
Pontillo J; Tran JA; Arellano M; Fleck BA; Huntley R; Marinkovic D; Lanier M; Nelson J; Parker J; Saunders J; Tucci FC; Jiang W; Chen CW; White NS; Foster AC; Chen C
Bioorg Med Chem Lett; 2004 Sep; 14(17):4417-23. PubMed ID: 15357964
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands.
Bakshi RK; Hong Q; Tang R; Kalyani RN; Macneil T; Weinberg DH; Van der Ploeg LH; Patchett AA; Nargund RP
Bioorg Med Chem Lett; 2006 Mar; 16(5):1130-3. PubMed ID: 16364639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
